Cidara Therapeutics, Inc. (CDTX) Has Descending Triangle Chart Pattern Trading At $3.00

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Corporate Logo

The descending triangle that had Cidara Therapeutics, Inc. (CDTX) has $3.24 price target or 8.00 % above today’s $3.00 stock price. The chart setup had indicates low risk. At $3.24 price target, the company’s valuation could be $6.66M more.

CDTX is hitting $3 during the last trading session, after decreased 2.60%.Cidara Therapeutics, Inc. has volume of 34,438 shares. Since December 12, 2017 CDTX has declined 61.01% and is downtrending. CDTX underperformed the S&P 500 by 61.01%.

On February, 26 WallStreet awaited Cidara Therapeutics, Inc. (NASDAQ:CDTX)’s earnings report, Zacks reports. Analysts have anticipation on stock’s earnings per share of $-0.54. That’s up 21.74 % from last year’s $-0.69 earnings per share. Wall Street forecasts 10.20 % negative EPS growth as of February, 26.

For more Cidara Therapeutics, Inc. (NASDAQ:CDTX) news published briefly go to: Zacks.com, Businesswire.com, 247Wallst.com, 247Wallst.com or Benzinga.com. The titles are as follows: “Cidara Therapeutics Sees Hammer Chart Pattern: Time to Buy? – Zacks.com” published on July 30, 2018, “Mainstay Medical Announces the Appointment of Matthew Onaitis as Chief Financial Officer – Business Wire” on August 20, 2018, “5 Stocks Trading Under $10 With Gigantic Upside Potential – 24/7 Wall St.” with a publish date: July 28, 2018, “5 Stocks Trading Under $10 That Have Huge Upside Potential – 24/7 Wall St.” and the last “The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines (June 3-9) – Benzinga” with publication date: June 03, 2018.

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.